Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. - Wikidata - awgldk - TriplyDB

Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study.

Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study.

http://www.wikidata.org/entity/Q34206710

about

Uric acid in metabolic syndrome: From an innocent bystander to a central player Metabolic factors and chronic hepatitis C: a complex interplay Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.The Wide and Complex Field of NAFLD Biomarker Research: Trends.Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients.Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Obesity-related cardiorenal disease: the benefits of bariatric surgery.Non-alcoholic fatty liver disease: factors associated with its presence and onset.Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China.Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population.Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver

P2860

Q26772053-3C02479F-6F3C-40CD-8640-50EF74543F66 Q27011787-EF6903A3-E2E5-4BE5-BC68-5F086EA3F0CB Q28354735-AF3B55FB-F6F7-4958-A182-51332BE621C9 Q30393424-1D8CE573-AD08-459B-A62B-92D5B5B7852B Q30572017-B27CF53D-A477-40F2-A06D-4C224AE911D6 Q33693601-C9BAEEF9-8AA0-45E0-9FA0-E80CF42ED682 Q34172798-E54FB568-3D0C-4552-91B5-A00DE2911DAE Q34415002-C46715C9-A582-450F-8CC4-BE1B6BB9BFEE Q35523269-7D2F2378-E246-4C00-BE69-BD1EDD8B4FD4 Q35810113-751A4B8C-DE94-49E9-BDE9-085473C43BB9 Q35927066-6A36BE94-C0C1-4954-9137-1D533145CBAF Q36418940-807C4E4A-59CA-4CF9-9477-C3EB00F61065 Q36962085-6561809D-EE4A-4CA8-82FA-0C86103B6B4D Q37038253-9B707F88-3856-418F-9ED9-3725892E830F Q37479795-EC780FB1-4962-42B9-969D-DDCC9879083F Q37488800-5A96D86A-1E7F-42B4-996F-CFDE7A6520D5 Q38126800-469A8123-ED15-4F04-9B24-1A96B574BDC6 Q38164074-1957F4E8-A058-48B8-BDD7-710D24A9C063 Q38595252-EBDCB9E5-D678-45B8-AE23-6C90F2950A18 Q38670507-63CE438A-EB87-41A4-9F88-56C99C762FEA Q38791485-87330BB7-2DBE-4A05-9803-17DC190DD404 Q39021862-F4FA649A-2CE0-4FE7-A248-6EF5EECFF85F Q39724638-8564A719-5A42-4B47-89B4-B78E36FCF08A Q42981990-C3AC11D6-F563-4FA7-A91D-FD35A5FC103D Q44037265-02F91DA1-6E3C-47CB-A7F7-23F95CA4D6DC Q50133288-F282BF0F-6E9E-4369-A6BA-854B468B133D Q50147806-D2F04035-59A9-4AF9-967A-3FDB39EE2699 Q51248110-C604DAD1-55D2-4415-9273-C1AB026B6D5E Q55620377-C7543C30-3779-4D63-ABA2-35D764487935 Q58546160-B0F3D907-313B-4E0C-955B-429C4EEA8FC5 Q58799660-147DE690-2186-44EA-85F4-1F6DBB1D5B49

P2860

Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study.

http://www.wikidata.org/entity/Q34206710

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@ast

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@en

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@nl

type

label

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@ast

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@en

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@nl

prefLabel

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@ast

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@en

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@nl

P1433

Q34206710-EDDCF858-A119-4679-8B16-A9EB84E47AAC

P1476

Q34206710-5A0FD7B7-8AD3-45BF-BCA2-6FEB7983D7DE

P2093

Q34206710-2D1C6FCC-FC9F-48BA-AF8C-F1A3F3258138

Q34206710-2FA25184-D755-4741-983E-4925E3E94A8C

Q34206710-32F6961E-9F70-4685-8A07-C0360A9C8CEB

Q34206710-3CFEDA6D-F1A8-49A4-A65B-6AADB4941DF4

Q34206710-6A1CB081-98F5-42F2-BC3A-2F6E70532D1A

Q34206710-72BAE4C6-84EB-465F-879B-3CF7C7FB639C

Q34206710-84BA9E82-71A6-4D0F-9902-6DFB1C8CD1D7

Q34206710-D6307E4C-CA96-4BDA-8A7A-2E5AD56F18C6

Q34206710-EE50217E-4987-48AC-9DD5-E250F68D631C

Q34206710-FECF23F6-7963-401B-BFC9-08477463410E

P2860

Q34206710-03507F7C-570E-40B9-B788-9F56052BD3F6

Q34206710-03F92310-BCD8-4473-8420-DB51A2BCE01A

Q34206710-0993635C-011F-4A43-A075-C849469A140C

Q34206710-0C836BB6-03AD-45E6-98F4-34155D16EB66

Q34206710-0F07F9BF-A37B-4E38-AB6D-264670940D92

Q34206710-1B05970C-1BA8-4E5E-AC5D-7317CC715F2C

Q34206710-3C3D6657-5EF1-43DC-AAFB-9772D38F1CD0

Q34206710-4D07A2A8-708B-4B35-978B-0B7447A8C43D

Q34206710-4D9F79FF-7E66-4E07-BFFC-242E1A6A15EF

Q34206710-65E3182E-969D-4523-8F30-94CA2D623917

P304

Q34206710-035C80BB-0B14-481B-941A-05618A5C2865

P31

Q34206710-73CD6898-A8FE-458C-BE98-90FCCD624747

P356

Q34206710-E97AC11A-BCBF-4356-85B0-0814D1525186

P433

Q34206710-828C672F-7D26-4EF1-88DB-DA1A7A60528E

P478

Q34206710-88F3925F-899C-47CA-94A8-039A2894619E

P577

Q34206710-5B273408-8CDA-44EA-9E4C-6A80611F663E

P5875

Q34206710-4E12BA86-0565-4935-A437-8D66F37EE755

P698

Q34206710-65DDEC52-F166-4A85-8005-E2CE02E390A4

P932

Q34206710-A73F5B3E-7CF6-4C0A-8C9C-32F82BAD5CA7

P356

GNL.2010.4.3.378

P1433

P1476

Serum uric Acid as a predictor ...... ar retrospective cohort study.

@en

P2093

Bum Soo Kim

http://www.w3.org/2001/XMLSchema#string

Eugene Chang

http://www.w3.org/2001/XMLSchema#string

Hyang Kim

http://www.w3.org/2001/XMLSchema#string

Jae Woong Lee

http://www.w3.org/2001/XMLSchema#string

Jung Tae Kim

http://www.w3.org/2001/XMLSchema#string

Ki Chul Sung

http://www.w3.org/2001/XMLSchema#string

Kwan Joong Joo

http://www.w3.org/2001/XMLSchema#string

Mc Ryan

http://www.w3.org/2001/XMLSchema#string

Seung Won Lee

http://www.w3.org/2001/XMLSchema#string

Yong Kyun Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Banting lecture 1988. Role of insulin resistance in human disease

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Hyperuricemia and insulin resistance.

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.

Diagnosis of fatty liver disease: is biopsy necessary?

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

P304

378-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL.2010.4.3.378

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47567162

http://www.w3.org/2001/XMLSchema#string

P698

20981217

http://www.w3.org/2001/XMLSchema#string

P932

2956352

http://www.w3.org/2001/XMLSchema#string